Comparative Evaluation of PUSPENs and C&Cs
- Registration Number
- NCT02698098
- Lead Sponsor
- University of Malaya
- Brief Summary
This observational study compares the health and social outcomes between opioid-dependent individuals who are either recently released from a compulsory drug detention center (CDDC) or recently discharged from a voluntary treatment center (VTC) providing methadone maintenance therapy, in Malaysia.
- Detailed Description
In July 2010, the National Anti-Drug Agency of Malaysia (NADA) introduced a non-punitive system of treatment and care for people who use drugs, voluntary treatment centers (VTCs), called 'Cure \& Care' clinics, offering free methadone maintenance therapy (MMT) to opioid-dependent drug users. These centers were opened alongside existing compulsory drug detention centers (CDDCs), where people who use drugs continue to be detained involuntarily without access to evidence-based treatment. Given that both of these programs are operated by NADA but espouse vastly different responses to drug use, we compared health and social outcomes between opioid-dependent individuals recently released from CDDCs and recently initiated into MMT in the new VTCs.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 281
- Meets Diagnostic and Statistical Manual-IV criteria for opioid dependence
- Physically and psychologically capable of understanding and undergoing informed consent process
- Within 90 days of release or discharge and intending to return to Klang Valley region
- For VTC arm, came to the C&C to start MMT
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Voluntary Treatment Center Methadone Voluntary drug treatment facilities, called 'Cure and Care' centers in Malaysia, that provide methadone maintenance therapy in addition to psychosocial interventions, recreational programming, and vocational training, among other activities.
- Primary Outcome Measures
Name Time Method Occurrence of opioid use (urine-toxicology) Year following release from CDDC or discharge from VTC
- Secondary Outcome Measures
Name Time Method Occurrence of any drug use (urine-toxicology) Year following release from CDDC or discharge from VTC Includes opioid, amphetamine and benzodiazepine use
Occurrence of amphetamine use (urine-toxicology) Year following release from CDDC or discharge from VTC Occurrence of benzodiazepine use (urine-toxicology) Year following release from CDDC or discharge from VTC Occurrence of methadone use (urine-toxicology) Year following release from CDDC or discharge from VTC This is a proxy for linkage to methadone therapy
Occurrence of buprenorphine use (urine-toxicology) Year following release from CDDC or discharge from VTC This is a proxy for linkage to buprenorphine therapy
Occurrence of no-methadone use (urine-toxicology) Year following release from CDDC or discharge from VTC This is a proxy for retention in methadone therapy